Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen Inc. | 0.17% | 358.71 | 1.2% | $830.53m | |
| AMGN | Amgen Inc. | -0.66% | 190.49 | 1.2% | $543.11m | |
| CELG | Celgene Corporation | -0.28% | 85.10 | 1.2% | $507.54m | |
| GILD | Gilead Sciences, Inc. | 0.42% | 77.37 | 0.9% | $473.45m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.51% | 177.40 | 1.9% | $313.54m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.17% | 367.11 | 2.6% | $276.88m | |
| ILMN | Illumina, Inc. | 0.66% | 311.15 | 3.5% | $269.38m | |
| BLUE | Bluebird Bio, Inc. | 0.78% | 180.35 | 15.7% | $197.52m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.64% | 133.31 | 16.6% | $196.81m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.05% | 135.16 | 2.0% | $178.57m | |
| NKTR | Nektar Therapeutics | -0.71% | 48.73 | 5.6% | $172.03m | |
| EXAS | Exact Sciences Corporation | 0.02% | 67.62 | 25.4% | $155.70m | |
| EXEL | Exelixis, Inc. | -0.23% | 21.29 | 6.4% | $135.36m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.94% | 101.90 | 4.4% | $122.64m | |
| A | Agilent Technologies, Inc. | -0.45% | 63.86 | 1.5% | $110.57m |
Company Profile
Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the development and discovery of novel vaccines and immuno-oncology therapeutics. It focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.